Known Safety News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Known Safety. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Known Safety Today - Breaking & Trending Today

Neurocrine Biosciences Presents Phase 3 Data for KINECT-HD Study Evaluating Valbenazine for Chorea Associated with Huntington Disease at AAN 2022

Published: April 1, 2022

- Valbenazine Met the Primary Endpoint of Significant (p<0.0001) Improvement in Chorea Severity versus Placebo as Measured by the Unified Huntington's Disease...

Source: prnewswire.com

Related Topics:

United StatesEiryw RobertsNeurocrine BiosciencesHuntington Study GroupAmerican Academy Of NeurologyDrug AdministrationClinical Trials Coordination CenterPrnewswire Neurocrine Biosciences IncPrimary EndpointTotal Maximal ChoreaImprovements BeginningMeaningful ResultsGreater Response RatesSafety ProfileKnown SafetySubmit Supplemental New Drug ApplicationEmerging Science SessionAmerican AcademyChief Medical Officer